| 000 | 01758 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517140146.0 | ||
| 264 | 0 | _c20170717 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1558-3597 | ||
| 024 | 7 |
_a10.1016/j.jacc.2016.11.055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalløe, Anders M | |
| 245 | 0 | 0 |
_a10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cFeb 2017 |
||
| 300 |
_a616-624 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xsurgery |
| 650 | 0 | 4 |
_aCoronary Restenosis _xepidemiology |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraft Occlusion, Vascular _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunosuppressive Agents |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPaclitaxel |
| 650 | 0 | 4 | _aSirolimus |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKelbæk, Henning | |
| 700 | 1 | _aThuesen, Leif | |
| 700 | 1 | _aHansen, Henrik S | |
| 700 | 1 | _aRavkilde, Jan | |
| 700 | 1 | _aHansen, Peter R | |
| 700 | 1 | _aChristiansen, Evald H | |
| 700 | 1 | _aAbildgaard, Ulrik | |
| 700 | 1 | _aStephansen, Ghita | |
| 700 | 1 | _aLassen, Jens F | |
| 700 | 1 | _aEngstrøm, Thomas | |
| 700 | 1 | _aJensen, Jan Skov | |
| 700 | 1 | _aJeppesen, Jørgen L | |
| 700 | 1 | _aBligaard, Niels | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 69 _gno. 6 _gp. 616-624 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2016.11.055 _zAvailable from publisher's website |
| 999 |
_c26867053 _d26867053 |
||